The Patent Trial and Appeal Board (PTAB) has impacted two patents owned by New York University (NYU). NYU has been embroiled in a lawsuit with a San Diego-based firm, accusing the latter of allegedly employing their patented technology in a brand of devices. These compact machines have been marketed for the treatment of sleep disorders.
The decision by the PTAB may carry significant implications for both parties involved in the ongoing litigation. For NYU, their claims of patent infringement may be undermined, while for the San Diego firm, the decision could offer some degree of reprieve. It remains to be seen how this development shapes the course of the lawsuit, and what its broader implications might be for patent disputes in the health technology sector.
For a more detailed examination of the PTAB’s critiques and the potential consequences for NYU’s litigation, read the original report here.